Professor Dennis Black

A recognized expert in the field of osteoporosis, Dr. Black has over 20 years of experience in designing, managing and reporting results from large randomized trials and observational studies of osteoporosis. He has served as the overall study principal investigator for several landmark osteoporosis trials including the FIT/FLEX trials of alendronate, the PaTH trial (NIAMS-funded study of PTH combination) and the HORIZON trial of zoledronic acid. He has a PhD in Biostatistics from UC Berkeley and has worked as a Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco since 1987. He is also Head of the Division of Chronic Diseases at UCSF. He has published over 250 papers and has been first author on several landmark randomized trials in the area of osteoporosis in such journals as New England Journal of Medicine (6 articles), Lancet and JAMA.  He was first author on a New England Journal Clinical Practice review of post-menopausal osteoporosis published in January of this year.

Supported By